160 related articles for article (PubMed ID: 23881993)
21. Final rule on additional protections for women.
Maloney DM
Hum Res Rep; 2002 Jan; 17(1):3. PubMed ID: 16270436
[No Abstract] [Full Text] [Related]
22. Oxygen administration to the premature infant. A two-edged sword.
Patz A
Am J Ophthalmol; 1967 Feb; 63(2):351-3. PubMed ID: 6071246
[No Abstract] [Full Text] [Related]
23. Retrolental fibroplasia--a continuing program.
Alfano JE
Trans Am Acad Ophthalmol Otolaryngol; 1970; 74(1):18-27. PubMed ID: 5467248
[No Abstract] [Full Text] [Related]
24. Giving small babies oxygen: 50 years of uncertainty.
Tin W; Wariyar U
Semin Neonatol; 2002 Oct; 7(5):361-7. PubMed ID: 12464498
[TBL] [Abstract][Full Text] [Related]
25. Phototherapy and other ocular risks to the newborn.
Patz A; Souri EN
Sight Sav Rev; 1972; 42(1):29-33. PubMed ID: 5067722
[No Abstract] [Full Text] [Related]
26. [Incidence of retrolental fibroplasia in low birth weight infants receiving oxygen therapy].
Horváth M; Vastagh O; Rubecz I; Heim T
Orv Hetil; 1981 Aug; 122(32):1943-6. PubMed ID: 7029395
[No Abstract] [Full Text] [Related]
27. [Oxygen therapy and prematurity: lessons from the past].
Duc G
Schweiz Med Wochenschr; 1993 Mar; 123(12):547-53. PubMed ID: 8475363
[TBL] [Abstract][Full Text] [Related]
28. [Are there predictors for proliferative retinopathy of prematurity and is supplemental oxygen a useful conservative treatment option?].
Müller H; Weiss C; Kuntz S; Akkoyun I; Schaible T
Klin Padiatr; 2005; 217(2):53-60. PubMed ID: 15770574
[TBL] [Abstract][Full Text] [Related]
29. [Retrolental fibroplasia and the so-called medical ethics].
Crone RA
Ned Tijdschr Geneeskd; 1974 Jul; 118(28):1069-72. PubMed ID: 4408101
[No Abstract] [Full Text] [Related]
30. Hospital ERs on the front line in informed-consent debate.
Wolpe PR; Menz JF
Forum Appl Res Public Policy; 1997; ():127-31. PubMed ID: 14628849
[No Abstract] [Full Text] [Related]
31. [Problems of the prevention of retrolental fibroplasia].
Prost M
Pediatr Pol; 1984 Jun; 59(6):507-11. PubMed ID: 6548806
[No Abstract] [Full Text] [Related]
32. Institutional review boards, research on children, and informed consent of parents: walking the tightrope between encouraging vital experimentation and protecting subjects' rights.
Katerberg RJ
J Coll Univ Law; 1998; 24(3):545-79. PubMed ID: 16331880
[No Abstract] [Full Text] [Related]
33. SUPPORT controversy's lessons for informed consent.
Furlow B
Lancet Respir Med; 2015 Dec; 3(12):928-9. PubMed ID: 26453139
[No Abstract] [Full Text] [Related]
34. Foreseeable risks? Informed consent for studies within the standard of care.
Sacks CA; Warren CE
N Engl J Med; 2015 Jan; 372(4):306-7. PubMed ID: 25517574
[No Abstract] [Full Text] [Related]
35. The need for further research in retrolental fibroplasia.
Patz A
Sight Sav Rev; 1970; 40(1):7-11. PubMed ID: 5468139
[No Abstract] [Full Text] [Related]
36. Effect of decreasing target oxygen saturation on retinopathy of prematurity.
Leenheer R; Wright K; Lee T
J AAPOS; 2011 Apr; 15(2):217; author reply 217-8. PubMed ID: 21463959
[No Abstract] [Full Text] [Related]
37. [Comparison of O2-exposed premature infants with and without vitamin E substitution from the ophthalmologic viewpoint].
Burgold R; Krebs W; Menzel K
Kinderarztl Prax; 1989 Feb; 57(2):71-6. PubMed ID: 2724777
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment: oxygen therapy and retrolental fibroplasia. Report of a conference.
Silverman WA
Pediatrics; 1969 Jan; 43(1):88-9. PubMed ID: 5818255
[No Abstract] [Full Text] [Related]
39. Retrolental fibroplasia and oxygen administration during general anesthesia.
Betts EK; Downes JJ; Schaffer DB; Johns R
Anesthesiology; 1977 Dec; 47(6):518-20. PubMed ID: 579289
[No Abstract] [Full Text] [Related]
40. Numerous violations of federal informed consent requirements.
Maloney DM
Hum Res Rep; 2004 Jan; 19(1):1-3. PubMed ID: 14997901
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
